| Description | Tilarginine citrate is a competitive nitric oxide synthetase inhibitor. |
| Synonyms | L-Ng-monomethyl arginine citrate |
| molecular weight | 380.354 |
| Molecular formula | C13H24N4O9 |
| CAS | 209913-88-2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| References | 1. Ricciardolo FL, Rado V, Fabbri LM, Sterk PJ, Di Maria GU, Geppetti P. Bronchoconstriction induced by citric acid inhalation in guinea pigs: role of tachykinins, bradykinin, and nitric oxide. Am J Respir Crit Care Med. 1999 Feb;159(2):557-62. PubMed PMID: 9927373. 2. Kimura M, Higashi Y, Hara K, Noma K, Sasaki S, Nakagawa K, Goto C, Oshima T, Yoshizumi M, Chayama K. PDE5 inhibitor sildenafil citrate augments endothelium-dependent vasodilation in smokers. Hypertension. 2003 May;41(5):1106-10. Epub 2003 Apr 14. PubMed PMID: 12695418. 3. Kaluski E, Uriel N, Milo-Cotter O, Klapholz M. Nitric oxide synthase inhibitors in cardiogenic shock: present and future. Future Cardiol. 2008 Mar;4(2):183-9. doi: 10.2217/14796678.4.2.183. PubMed PMID: 19804295. 4. Clancy RM, Gomez PF, Abramson SB. Nitric oxide sustains nuclear factor kappaB activation in cytokine-stimulated chondrocytes. Osteoarthritis Cartilage. 2004 Jul;12(7):552-8. PubMed PMID: 15219570. |